Carrie Smith Email & Phone Number

Boston, Massachusetts, Us

An accomplished contributor advancing the adoption of Fotivda (Tivozanib). An oral VEGFR TKI for patients with metastatic relapsed or refractory advanced renal cell carcinoma (mRCC) after two or more prior systemic therapies. Providing support to Medical Oncology, Hematology Oncology community cancer centers, large academic centers, Genitourinary centers of excellence and Federal VA accounts.2024 Ranked #5 YTD for Presidents Club, 142% to goal Q3, 137% to goal Q22024 63% YTD growth 2024 New Patient Contest Winner & Go For Gold Contest Leader2023 Ranked #7 106% attainment

Zug, Ch

Ensured top performance of Feraheme, an IV iron infusion to Hematologists, Oncologists, Medical Oncologists, Breast Oncologists, Nephrologists, Gastroenterologists, Hospitals, Pharmacy and Cancer Centers in a highly competitive and newly generic environment. Recognized as a company leader with deep clinical understanding, strategic approach and proudly serve as a trusted advisor for physicians. Proven success on maximizing pull-through efforts for GPO’s, IDN’s and buy & bill selling model. Twenty hospital P&T committee formulary wins, including Ohio State, Mount Carmel and Ohio Health. Adept at navigating complex managed care landscape. Cross functional leadership and collaboration with Medical Affairs, Strategic Account and Market Access. Advanced the treatment of Oral Mucositis to Radiation Oncologists with Mugard. 2022 Q2 105% to quota, 5th place in quota attainment 2022 Top 10% national ranking 2021 122% of quota, Top 5% Nationally ranked in Convert Contest 2021 Appointed Buddy Program Liaison by Leadership, Feraheme Assist Task Force 2020 100% to plan during COVID, Marketing Advisory Board 2020 Selected as National and Regional Sales Trainer, Feraheme Advisory Board 2020 MVP for highest volume of virtual appointments during Covid 2019 100% to plan, Promoted to Senior Specialty Oncology Hematology Account Manager 2018 113% to plan, Ranked #1 Nationally in 6 month Convert Contest 2017 Team of the Year Converted Key Accounts: Ohio State University, Mount Carmel East, West and St. Anne's, Zangmeister Cancer Center, Columbus Oncology, Adena Hospital, Wheeling Hospital, Lima Memorial Hospital, Mercy Medical Center Cleveland Clinic, Fairfield Medical Center, Licking Memorial, St. Ritas/Mercy Health, Memorial Hospital of Union County, Knox Community Hospital, WVU Reynolds and Camden Clark, Southeastern RMC, Tri County Hematology Oncology, Orion Cancer Care.

Zug, Ch

Led successful launch of a new minimally invasive, laparoscopic, outpatient surgical treatment option for symptomatic uterine fibroids to OB-Gyn's in a five state region. The Acessa procedure uses radio-frequency ablation technology along with ultrasound guidance and electromagnetic tracking to predict trajectory in relation to the ultrasound plane for targeting fibroids of virtually all sizes, types and locations within the uterus.Company filed bankruptcy and eliminated all field sales representatives.2016 244% Revenue Goal2016 101% Procedure Goal2015 Year End Highest Achievement Award - # of new users2015 Field Sales Trainer

Aliso Viejo, Ca, Us

Launched the MILD procedure for (LSS) lumbar spine stenosis as a new conceptual, disruptive and paradigm shifting technology platform that competed against the standard of care; hysterectomies. Responsible for hospital and surgery center credentialing process for new physicians. Provided operating room and case management for this fluoroscopically guided, minimally invasive lumbar decompression procedure with a Category III CPT code and limited reimbursement. Guided new procedure technology through value analysis committees and C-suites for hospital or surgery center approval. Call points included: Pain Management, Interventional Radiology, Spine and Neurology.This start up spine company eliminated all field sales territory managers after losing Medicare coverage along with the added burden to further develop clinical safety trials as requested by the FDA.2014 Over achievement bonus2014 52% increase in revenue in first 6 months2013 160% growth in sales Q3 over Q42013 Top ten leaderboard for highest revenue or case growth2013 95% increase in volume of cases on anchor physicians during first 90 days2013 Re-engaged three physicians who previously discontinued doing procedures

Us

Uroplasty Inc. is a global medical device company that develops, manufacturers and markets products for the minimally invasive treatment of voiding dysfunctions and pelvic disorders. Sold a surgical urethral soft tissue bulking implant called Macroplastique for stress incontinence and a percutaneous tibial neuromodulation procedure (Urgent PC) for over active bladder. Negotiated pricing and contracts for hospitals and surgery centers. Provided operating room consultation and training to Urologists, Gynecologists and Uro-gynecologists. 2013 41% increase in sales2013 Highest regional sales for Urgent PC2012 Top 10% in new business, 42 new accounts2012 Highest regional sales for Urgent PC2012 Regional Contest Winner2012 Top 10% in re-engaged account uptake, 13 accounts2011 Top 13% in new business, 30 new accounts2010 Winner of National New Account Contest2010 Winner of Blitz Contest

Yardley, Pa, Us

Responsible for selling multiple therapeutic lines within Urology, Ob-Gyn, Cardiology and Internal Medicine. Developed and executed strategic plans to maximize sales growth. Sustained loyalty through consultative selling and resource partnering. Devised competitive strategies against new competitors. Adept at sales execution, need identification and clinical knowledge.2010 Above and Beyond Award Winner2010 Field trainer for new representatives2009 Achieved Top Bonus Payout for quota attainment

Palo Alto, Ca, Us

Played integral part of the first commercial sales team to launch a new anti-anginal technology for a start-up company to hospitals and teaching institutions with third tier insurance coverage. Created advocacy among academic thought leaders. Lead efforts for successful formulary acceptance and subsequent pull through strategies. Consistently recognized as a top performer, both regionally and nationally. 2007 Top 17%, ranked #43 of 2502006 Top 13%, ranked #33 of 2502006 Recipient of National Fast Start New Product Launch Award

New York, New York, Us

2005 Top 2%, ranked #2 of 90, Regional Caduet Launch Winner2004 Regional Performance Bonus, Regional Summit Achievers Conference, Winner’s Choice Award2003 Convention Award Trip, Top 2%, Ranked #2 of 90, Regional Winner’s Choice Award 2002 District Representative of the Year 2002 Consistent Achiever's Bonus Award Winner, Women's Leadership Conference, Viagra 500 Winner2001 Top 10 % rank, Women’s Leadership Advisory Panel 2001 Presidents Club Winner, District Rep of the Year2000 District Winner's Choice Contest, Men’s Health Level 1 Winner1999 District Rep of 4th Quarter